BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.91B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.41B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$704M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$665M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$115M |
| 2 |
iShares US Financials ETF
IYF
|
+$109M |
| 3 |
Visa
V
|
+$108M |
| 4 |
Charter Communications
CHTR
|
+$73.8M |
| 5 |
Honeywell
HON
|
+$58.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.66% |
| 2 | Healthcare | 6.66% |
| 3 | Financials | 5.71% |
| 4 | Consumer Discretionary | 5.02% |
| 5 | Communication Services | 4.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CALA
3201
DELISTED
Calithera Biosciences, Inc
CALA
| $75K | ﹤0.01% |
845
+320
| +61% | +$38.1K |
|
3202
Bally's
BALY
$660M
| $74.8K | ﹤0.01% |
5,751
+2,818
| +96% | +$65K |
|
3203
Byline Bancorp
BY
$1.78B
| $74.7K | ﹤0.01% |
7,205
+1,543
| +27% | +$26.1K |
|
3204
Citizens & Northern Corp
CZNC
$466M
| $74.4K | ﹤0.01% |
3,721
+828
| +29% | +$20.1K |
|
|
CGC
3205
Canopy Growth
CGC
$426M
| $74.3K | ﹤0.01% |
515
+10
| +2% | +$1.88K |
|
3206
Consolidated Water Co
CWCO
$502M
| $74K | ﹤0.01% |
4,512
+976
| +28% | +$16.3K |
|
|
ALBO
3207
DELISTED
Albireo Pharma Inc
ALBO
| $73.9K | ﹤0.01% |
4,513
+3,004
| +199% | +$66.1K |
|
3208
Ooma
OOMA
$574M
| $73.8K | ﹤0.01% |
6,188
+3,345
| +118% | +$42.3K |
|
3209
Clean Energy Fuels
CLNE
$395M
| $73.7K | ﹤0.01% |
41,426
+8,741
| +27% | +$19.7K |
|
|
JCAP
3210
DELISTED
Jernigan Capital, Inc.
JCAP
| $73.6K | ﹤0.01% |
6,718
+1,475
| +28% | +$25.9K |
|
|
CORR
3211
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $73.6K | ﹤0.01% |
4,003
+760
| +23% | +$28.8K |
|
|
CUTR
3212
DELISTED
Cutera, Inc.
CUTR
| $73.6K | ﹤0.01% |
5,633
+2,446
| +77% | +$61.7K |
|
3213
Caesarstone
CSTE
$105M
| $73.5K | ﹤0.01% |
6,958
+1,558
| +29% | +$19K |
|
3214
ACNB Corp
ACNB
$660M
| $73.5K | ﹤0.01% |
2,451
+779
| +47% | +$25.1K |
|
|
RUTH
3215
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $73.4K | ﹤0.01% |
10,984
+1,786
| +19% | +$31K |
|
3216
KALA BIO
KALA
$17.9M
| $73.1K | ﹤0.01% |
3
+1
| +50% | +$16K |
|
3217
Cytosorbents Corp
CTSO
$22.8M
| $72.9K | ﹤0.01% |
9,435
+5,169
| +121% | +$26.1K |
|
3218
Cooper-Standard Automotive
CPS
$484M
| $72.6K | ﹤0.01% |
7,071
-244
| -3% | -$5.24K |
|
|
ACRE
3219
Ares Commercial Real Estate
ACRE
$264M
| $72.4K | ﹤0.01% |
10,353
+3,563
| +52% | +$50.5K |
|
|
DX
3220
Dynex Capital
DX
$3.23B
| $72.2K | ﹤0.01% |
6,920
+1,117
| +19% | +$18.4K |
|
|
CAI
3221
DELISTED
CAI International, Inc.
CAI
| $72.2K | ﹤0.01% |
5,104
+878
| +21% | +$21.1K |
|
3222
Daktronics
DAKT
$988M
| $72.2K | ﹤0.01% |
14,638
+1,404
| +11% | +$7.79K |
|
|
SMMF
3223
DELISTED
Summit Financial Group, Inc.
SMMF
| $72K | ﹤0.01% |
3,394
+752
| +28% | +$17.4K |
|
3224
CALL
EOG Resources
EOG
$74.2B
| $71.8K | ﹤0.01% |
20
-843
| -98% | -$54.8K |
|
|
CNCE
3225
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $71.7K | ﹤0.01% |
8,116
+2,904
| +56% | +$28.6K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2020 Portfolio in Review
As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.
- BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
- BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
- BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
- BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
- BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
- BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.